Intellia Therapeutics
NTLA
#4977
Rank
โ‚ฌ1.57 B
Marketcap
11,24ย โ‚ฌ
Share price
-8.33%
Change (1 day)
59.69%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2025 (TTM): -3,34ย โ‚ฌ

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is -3,29ย โ‚ฌ. an increase over its 2024 EPS that were of -4,51ย โ‚ฌ.

EPS history for Intellia Therapeutics from 2016 to 2025

Annual EPS

Year EPS Change
2025-3,29ย โ‚ฌ-27.05%
2024-4,51ย โ‚ฌ-2.96%
2023-4,65ย โ‚ฌ-12.46%
2022-5,31ย โ‚ฌ64.36%
2021-3,23ย โ‚ฌ56.67%
2020-2,06ย โ‚ฌ
2018-1,71ย โ‚ฌ6.99%
2017-1,60ย โ‚ฌ71.4%
2016-0,93ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,31ย โ‚ฌ-60.31%๐Ÿ‡บ๐Ÿ‡ธ USA